Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giuseppe Boni

Showing results (51-60 of 60) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 60 results.
Clinical Nuclear Medicine|October 9, 2015
Sentinel Lymph Node Biopsy in Breast Cancer: Indications, Contraindications, and ControversiesGianpiero Manca, Domenico Rubello, Elisa Tardelli, et al.
Cancer Biotherapy & Radiopharmaceuticals|May 5, 2005
Comparison of different thyroid committed doses in radioiodine therapy for Graves' hyperthyroidismMariano Grosso, Antonio Traino, Giuseppe Boni, et al.
Cardiovascular and Interventional Radiology|July 10, 2020
Yttrium-90 Radioembolization in Unresectable Intrahepatic Cholangiocarcinoma: Results of a Multicenter Retrospective StudyIrene Bargellini, Cristina Mosconi, Giuseppe Pizzi, et al.
Revista Espanola De Medicina Nuclear E Imagen Molecular|December 3, 2014
Disseminated bone metastases from occult thyroid cancer effectively treated with debulking surgery and a single dosimetry-guided administration of radioiodineElisa Borsò, Giuseppe Boni, Sara Mazzarri, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 17, 2008
Radionuclide evaluation of the lower gastrointestinal tractGiuliano Mariani, Ernest K J Pauwels, Abedallatif AlSharif, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 24, 2007
Clinical benefit of bone-targeted radiometabolic therapy with 153Sm-EDTMP combined with chemotherapy in patients with metastatic hormone-refractory prostate cancerSergio Ricci, Giuseppe Boni, Ilaria Pastina, et al.
European Thyroid Journal|September 20, 2022
Yttrium-90 transarterial radioembolization for liver metastases from medullary thyroid cancerLuciana Puleo, Laura Agate, Irene Bargellini, et al.
Journal of Nuclear Medicine Technology|March 17, 2026
Radiomics on <sup>177</sup>Lu-DOTATATE Posttreatment Scans: Feasibility, Preprocessing Optimization, and Planar-SPECT ComparisonFlavio Montanini, Alessio Imperiale, Alice Monaci, et al.
Tumori|May 2, 2018
<sup>223</sup>Ra-chloride therapy in men with hormone-refractory prostate cancer and skeletal metastases: Real-world experienceGiuseppe Boni, Sara Mazzarri, Claudia Cianci, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 21, 2024
Lutetium [<sup>177</sup>Lu]-DOTA-TATE in gastroenteropancreatic-neuroendocrine tumours: rationale, design and baseline characteristics of the Italian prospective observational (REAL-LU) studySecondo Lastoria, Marcello Rodari, Maddalena Sansovini, et al.
Pageof 6

Showing results (51-60 of 60) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
Clinical Nuclear Medicine|October 9, 2015
Sentinel Lymph Node Biopsy in Breast Cancer: Indications, Contraindications, and ControversiesGianpiero Manca, Domenico Rubello, Elisa Tardelli, et al.
Cancer Biotherapy & Radiopharmaceuticals|May 5, 2005
Comparison of different thyroid committed doses in radioiodine therapy for Graves' hyperthyroidismMariano Grosso, Antonio Traino, Giuseppe Boni, et al.
Cardiovascular and Interventional Radiology|July 10, 2020
Yttrium-90 Radioembolization in Unresectable Intrahepatic Cholangiocarcinoma: Results of a Multicenter Retrospective StudyIrene Bargellini, Cristina Mosconi, Giuseppe Pizzi, et al.
Revista Espanola De Medicina Nuclear E Imagen Molecular|December 3, 2014
Disseminated bone metastases from occult thyroid cancer effectively treated with debulking surgery and a single dosimetry-guided administration of radioiodineElisa Borsò, Giuseppe Boni, Sara Mazzarri, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 17, 2008
Radionuclide evaluation of the lower gastrointestinal tractGiuliano Mariani, Ernest K J Pauwels, Abedallatif AlSharif, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 24, 2007
Clinical benefit of bone-targeted radiometabolic therapy with 153Sm-EDTMP combined with chemotherapy in patients with metastatic hormone-refractory prostate cancerSergio Ricci, Giuseppe Boni, Ilaria Pastina, et al.
European Thyroid Journal|September 20, 2022
Yttrium-90 transarterial radioembolization for liver metastases from medullary thyroid cancerLuciana Puleo, Laura Agate, Irene Bargellini, et al.
Journal of Nuclear Medicine Technology|March 17, 2026
Radiomics on <sup>177</sup>Lu-DOTATATE Posttreatment Scans: Feasibility, Preprocessing Optimization, and Planar-SPECT ComparisonFlavio Montanini, Alessio Imperiale, Alice Monaci, et al.
Tumori|May 2, 2018
<sup>223</sup>Ra-chloride therapy in men with hormone-refractory prostate cancer and skeletal metastases: Real-world experienceGiuseppe Boni, Sara Mazzarri, Claudia Cianci, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 21, 2024
Lutetium [<sup>177</sup>Lu]-DOTA-TATE in gastroenteropancreatic-neuroendocrine tumours: rationale, design and baseline characteristics of the Italian prospective observational (REAL-LU) studySecondo Lastoria, Marcello Rodari, Maddalena Sansovini, et al.
Pageof 6